Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.

Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.

Item
http://www.wikidata.org/entity/Q38396594
In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and LimitationsReclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?Basal serum tryptase is not a risk factor for immediate-type drug hypersensitivity during childhood.Mastocytosis - pathogenesis, clinical manifestation and treatment.Mastozytose - Pathogenese, Klinik und Therapie.[Mastocytosis : Clinical aspects, diagnostics, therapy].Management of a Parturient with Mast Cell Activation Syndrome: An Anesthesiologist's Experience.Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.Perioperative drug reactions - practical recommendations for allergy testing and patient management.Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double-blind, placebo-controlled challenge study
P2860

Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.

Item
http://www.wikidata.org/entity/Q38396594
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.
@en
type
label
Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.
@en
prefLabel
Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698